SAVA - Cassava Bozor kapitallashuvining daromadga nisbati

Cassava Sciences Inc (SAVA) brendining ramzi va logotipi

Innovatsion Simufilam tomonidan ta'minlanadigan narxlarni belgilash imkoniyati pilot partiyalar uchun shartnomaviy ishlab chiqarish quvvatlarining joriy foydalanishi bilan zidlik tashkil etadi. GURU.Markets platformasidagi bozor kapitalizatsiyasining daromadga nisbati ko'rsatkichiga ko'ra, joriy parametr ga tengdir. Cassava Sciences, Inc. (SAVA) loyihasining muvaffaqiyati to'liq moliyaviy qo'llab-quvvatlash va korporativ bosimlardan xoli bo'lgan yetakchi neyrobiologlarning sinergiyasiga bog'liq.

Cassava Sciences (SAVA): P/S multiplikatori 04.07.2022dan 16.11.2026gacha

Cassava Sciences Inc (SAVA) kompaniyasining tahliliy kesimlari

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Kompaniyaning fundamental tahlili:Cassava Sciences (SAVA)
Cassava Sciences asosiy tovari

P/S koeffitsiyenti daromadning bir birligi uchun biznesning bozor qiymatini aks ettiradi va kelajakdagi pul oqimlari uchun to'langan premiumni baholash imkonini beradi. Cassava Sciences, Inc. (SAVA) uchun ushbu hisob-kitob juda muhimdir, chunki Altsgeymer kasalligini davolash patentlarining qiymati ko'pincha joriy savdolardan ustun keladi. Kompaniyaning normallashtirilgan P/S koeffitsiyentini tahlil qilish orqali investor spekulyativ kutishlar va haqiqiy daromad o'rtasidagi farqni aniqlashi mumkin. Bu qimmat klinika sinovlari davrida biznesning fundamental barqarorligini belgilaydi.

Raqobatdosh kompaniyalar

BIIB (Biogen) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori NBIX (Neurocrine Corp)|Regencell Bioscience - Narxning daromadga nisbati|Axsome Therapeutics - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati ACAD (ACADIA Pharmaceuticals)|Xenon (XENE) - Narxning daromadga nisbati|Sotuvga nisbatan narx Viking Therapeutics Inc (VKTX)|SUPN (Supernus Pharma) - P/S multiplikatori|CPRX: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori DNLI|Narx/daromad koeffitsiyenti Harmony Biosciences|Biohaven Ltd - Kapitalizatsiyaning daromadga nisbati|P/S multiplikatori Amylyx Pharmaceuticals, Inc. AMLX|TRVI: Kapitalizatsiyaning daromadga nisbati|Narx/daromad koeffitsiyenti Praxis Corp PRAX|AVXL: P/S multiplikatori|CBLL (ceribell.com) - Narxning daromadga nisbati|PRTA (Prothena Corporation) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati alector.com (ALEC)|Narxning daromadga nisbati Annexon, Inc. (ANNX)|OMER - Sotuvga nisbatan narx|P/S multiplikatori NGNE (Neurogene Inc)|AC Immune (ACIU) - Sotuvga nisbatan narx|Voyager Therapeutics Inc - P/S multiplikatori|Neumora (NMRA) - Kapitalizatsiyaning daromadga nisbati|SCLX: P/S multiplikatori|TVGN - Narx/daromad koeffitsiyenti|ACOG (Alpha Cognition Inc) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati cogrx.com (CGTX)|Narxning daromadga nisbati Inhibikase Therapeutics Inc (IKT)|Narx/daromad koeffitsiyenti Assertio|P/S multiplikatori COYA (Coya Therapeutics, Inc.)|Kapitalizatsiyaning sotish hajmiga nisbati VTGN (VistaGen Therapeutics Inc)|OVID: Kapitalizatsiyaning daromadga nisbati|ABOS: Narxning daromadga nisbati|CervoMed (CRVO) - Narxning daromadga nisbati|Sotuvga nisbatan narx Alterity Therapeutics Ltd (ATHE)|CLNN (Clene) - P/S multiplikatori|Kapitalizatsiya va daromad nisbati PEPG (PepGen)|Kapitalizatsiyaning daromadga nisbati JUNS (Jupiter Neurosciences, Inc.)|P/S multiplikatori relmada.com (RLMD)|Narxning daromadga nisbati Annovis Bio Corp ANVS|GRCE: Kapitalizatsiya va daromad nisbati|AIFF - Narxning daromadga nisbati|KLTO (anewmeds.com) - Kapitalizatsiya va daromad nisbati|NRSN (NeuroSense Therapeutics Ltd.) - Kapitalizatsiyaning daromadga nisbati|revivapharma.com - Bozor kapitallashuvining daromadga nisbati|MTVA (metaviatx.com) - P/S multiplikatori|NRXS: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori HSDT|PASG - Sotuvga nisbatan narx|P/S multiplikatori NEUP (Neuphoria Therapeutics)|NERV: Kapitalizatsiya va daromad nisbati|ATHA: Kapitalizatsiyaning daromadga nisbati|Addex Therapeutics Ltd - Kapitalizatsiyaning sotish hajmiga nisbati|Alzamend Neuro, Inc. (ALZN) - Narxning daromadga nisbati|CYCN (Cyclerion Therapeutics Inc.) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati PTIX|KTTA: Bozor kapitallashuvining daromadga nisbati|Kapitalizatsiyaning daromadga nisbati CRGT (Cortigent Medical)|ATXI (Avenue Therapeutics, Inc.) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Brainstorm Cell Therapeutics, Inc. BCLI|Bozor kapitallashuvining daromadga nisbati CARA|chromocell.com - P/S multiplikatori|Narxning sotuvga nisbati ELYM|ITCI: P/S multiplikatori|Sotuvga nisbatan narx Longboard Pharmaceuticals, Inc. (LBPH)|Narxning daromadga nisbati Marinus Pharmaceuticals, Inc.|NKGN: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori NRBO|SAGE: Narxning sotuvga nisbati|Synaptogenix Inc. - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati TRVN (Trevena Inc.)|Vigil Neuroscience, Inc. - P/S multiplikatori|Anew Medical (WENA) - Kapitalizatsiyaning daromadga nisbati|CERE (Cerevel Corp) - Kapitalizatsiyaning daromadga nisbati